China Animal Vaccine Industry Report, 2012-2015
  • Jun./2013
  • Hard Copy
  • USD $2,500
  • Pages:128
  • Single User License
    (PDF Unprintable)       
  • USD $2,400
  • Code: HK033
  • Enterprise-wide License
    (PDF Printable & Editable)       
  • USD $3,700
  • Hard Copy + Single User License
  • USD $2,700
In view of the frequent occurrence of animal epidemic diseases over the years, the Chinese government has increased investment in epidemic prevention and implemented compulsory immunization system. Beginning in 2004, it has gradually included highly pathogenic avian influenza, highly pathogenic PRRS (porcine reproductive and respiratory syndrome), classical swine fever and peste des petits ruminants in the national compulsory immunization coverage following the FMD (foot-and-mouth disease), thus leading to rapid growth in animal vaccine market size.

In 2004-2012, China’s animal vaccine market size grew at a CAGR as high as 26.4%, up to approximately RMB 9.1 billion in 2012 (including net import). For years to come, the market is expected to continue to maintain a growth rate of 15% or so, to RMB 15.9 billion in 2016.

China Animal Vaccine Market Size, 2000-2012

Chinese animal vaccine products include swine vaccine, poultry vaccine, cattle & sheep vaccine, pet and other vaccines. As pig and poultry breeding is the core of China’s animal husbandry, swine and poultry vaccines account for more than 85% of China’s animal vaccine market. In addition, the emerging pet industry is boosting vigorous growth in demand for pet vaccine, while there are few commercial pet vaccines from Chinese animal vaccine companies, mainly dependent on imported products with stiff prices. In future, the Chinese pet vaccine market will usher in large room for promotion.

In 2006, China carried out compulsory veterinary drug GMP certification, raised the industry access threshold, which brought a substantial decline in the number of animal vaccine enterprises, accompanied by increased industry concentration. In 2012, among domestic leading animal vaccine enterprises, China Animal Husbandry Industry Co., Ltd. made the highest animal vaccine revenue of RMB 1.17 billion, with market occupancy up to 12.9%; followed by Qingdao Yebio Bioengineering Co., Ltd (Zhejiang Shenghua Biok Biology Co., Ltd holds 38% stake), Xinjiang Tecon Animal Husbandry Bio-Technology Co., Ltd., Guangdong Dahuanong Animal Health Products Co., Ltd., Inner Mongolia Jinyu Group Stock Company, etc..

The Chinese animal vaccine market can be divided into two segments, i.e. government-procured compulsory immunization vaccines and market-oriented vaccines. Currently, there are merely five kinds of compulsory immunization vaccines, and more vaccines are market-oriented. However, in China, compulsory immunization vaccines still hold a market share of over 50%, with highly fierce competition but limited growth potential; by contrast, market-oriented vaccines will enjoy a larger space for development no matter in new product development or in animal protection improvement.

China Animal Vaccine Industry Report, 2012-2015 of ResearchInChina mainly covers the followings:
20120114.gif Market size, market structure, competition pattern, etc. of global animal vaccine industry;
20120114.gif Market size, market structure, competition pattern, import & export, etc. of China animal vaccine industry;
20120114.gif Policy environment, social environment, downstream demand, etc. of China animal vaccine industry;
20120114.gif Scale & structure prediction for China animal vaccine market and market segments;
20120114.gif Operation, animal vaccine business, forecast & outlook, etc. of 10 animal vaccine producers in China.

1. Overview of Animal Vaccine Industry
1.1 Definition
1.2 Classification
1.3 Industry Chain

2. Development Status of Animal Vaccine Industry
2.1 Status of International Animal Vaccine Industry
2.1.1 Market Size
2.1.2 Market Structure
2.1.3 Competition Pattern
2.1.4 New Diseases and New Products
2.2 Status of China Animal Vaccine Industry
2.2.1 Market Size
2.2.2 Market Structure
2.2.3 Import & Export
2.2.4 Profit Level
2.2.5 Entry Barriers
2.2.6 Competition Pattern

3. Development Environment of China Animal Vaccine Industry 
3.1 Policy Environment
3.1.1 Major Policies 
3.1.2 Compulsory Immunization Vaccine Tender System
3.2 Social Environment
3.2.1 Breeding Industry is Developing Steadily
3.2.2 Large-scale Breeding Becomes a Trend
3.2.3 Animal Epidemics Occur Frequently

4. Development Forecast of China Animal Vaccine Industry 
4.1 Overall Forecast
4.2 Swine Vaccine
4.2.1 Swine Fever Vaccine
4.2.2 FMD Vaccine
4.2.3 PRRS Vaccine
4.2.4 Porcine Circovirus Vaccine
4.3 Poultry Vaccine
4.4 Cattle & Sheep Vaccine
4.5 Pet Vaccine

5. Key Companies in China Animal Vaccine Industry 
5.1 China Animal Husbandry Industry Co., Ltd. (CAHIC)
5.1.1 Profile
5.1.2 Operation
5.1.3 Revenue Structure
5.1.4 Gross Margin
5.1.5 Animal Vaccine Business
5.1.6 Forecast & Outlook
5.2 Inner Mongolia Jinyu Group Stock Company
5.2.1 Profile
5.2.2 Operation
5.2.3 Revenue Structure
5.2.4 Gross Margin
5.2.5 R&D
5.2.6 Animal Vaccine Business
5.2.7 Forecast & Outlook
5.3 Xinjiang Tecon Animal Husbandry Bio-Technology Co., Ltd.
5.3.1 Profile
5.3.2 Operation
5.3.3 Revenue Structure
5.3.4 Gross Margin
5.3.5 R&D
5.3.6 Clients & Suppliers
5.3.7 Animal Vaccine Business
5.3.8 Forecast & Outlook
5.4 Ningbo TECH-BANK Co., Ltd.
5.4.1 Profile
5.4.2 Operation
5.4.3 Revenue Structure
5.4.4 Gross Margin
5.4.5 R&D
5.4.6 Animal Vaccine Business
5.4.7 Forecast & Outlook
5.5 Zhejiang Shenghua Biok Biology Co., Ltd.
5.5.1 Profile
5.5.2 Operation
5.5.3 Revenue Structure
5.5.4 Gross Margin
5.5.5 Clients
5.5.6 Animal Vaccine Business
5.5.7 Forecast & Outlook
5.6 Chengdu Huasun Group Inc. Ltd.
5.6.1 Profile
5.6.2 Operation
5.6.3 Revenue Structure
5.6.4 Gross Margin
5.6.5 Clients & Suppliers
5.6.6 Animal Vaccine Business
5.7 Tianjin Ringpu Bio-technology Co., Ltd.
5.7.1 Profile
5.7.2 Operation
5.7.3 Revenue Structure
5.7.4 Gross Margin
5.7.5 R&D
5.7.6 Animal Vaccine Business
5.7.7 Forecast & Outlook
5.8 Guangdong Dahuanong Animal Health Products Co., Ltd. (DHN)
5.8.1 Profile
5.8.2 Operation
5.8.3 Revenue Structure
5.8.4 Gross Margin
5.8.5 R&D
5.8.6 Animal Vaccine Business
5.8.7 Forecast & Outlook
5.9 Liaoning Yikang Biological Corporation Limited
5.9.1 Profile
5.9.2 Operation
5.9.3 Revenue Structure
5.9.4 Gross Margin
5.9.5 R&D
5.9.6 Clients & Suppliers
5.9.7 Animal Vaccine Business
5.10 Wuhan Chopper Biology Co., Ltd.
5.10.1 Profile
5.10.2 Operation
5.10.3 Revenue Structure
5.10.4 Gross Margin
5.10.5 R&D
5.10.6 Clients & Suppliers
5.10.7 Animal Vaccine Business
Animal Health Product Classification
Animal Vaccine Types (by Constituent and Property) and Features
Animal Vaccine Industry Chain
China Animal Disease Classification
Global Animal Vaccine Market Size, 2008-2016E
Basic Information of Global Animal Health Product Industry Giants 
Foreign Commercial Vaccines and Producers Over the Years
China Animal Vaccine Market Size, 2000-2012
China Animal Vaccine Product Structure by Animal Attribute, 2008-2012
China Animal Vaccine Market Structure by Sales Method
Compulsory Immunization Vaccine Product Producers in China, 2012
China Commercial Vaccine Classification and Market Situation
Import / Export Volume of Veterinary Vaccine in China, 2008-2013
Average Import / Export Price of Veterinary Vaccine in China, 2008-2013
China Veterinary Vaccine Import Countries by Import Volume, 2012
China Veterinary Vaccine Export Destination Distribution by Export Volume, 2012 
China Veterinary Vaccine Import Areas and % of Import Volume, 2012
China Veterinary Vaccine Export Areas and % of Export Volume, 2012
Gross Margin of Animal Vaccine Business of Leading Animal Vaccine Listed Companies in China, 2011-2012
Barriers to Enter China Animal Vaccine Industry
Main Products of Leading Animal Vaccine Producers in China, 2012
Revenue of Animal Vaccine Business of Major Animal Vaccine Listed Companies in China, 2011-2012
Major Gaps between Chinese Vaccine Production Technology Level and International Advanced Level
Sino-foreign Animal Vaccine Joint Ventures, 1990-2012
Major Policies on Animal Vaccine Industry in China, 2010-2013
National Animal Disease Compulsory Immunization Program in 2013
Animal Diseases with Priority to Prevention and Cure in China, 2013-2020
Defects of China’s Compulsory Immunization Tender System
Direction for China’s Compulsory Immunization Tender System Reform
Meat, Eggs and Milk Output in China, 2008-2012
Per Capita Consumption of Pork, Beef and Mutton in China, 2008-2012
China Meat Product Structure by Output, 2010-2012
Level of Large-scale Breeding in China, 2010-2020
Epidemic Prevention Costs of Pig Breeding in China, 2008-2012
Overview of Common Animal Epidemics in China
China Animal Epidemic Summary, 2013
China Animal Vaccine Market Size, 2012-2016E
China Animal Vaccine Market Structure by Animal Attribute, 2012 vs. 2016E 
Hog Breeding Stock and Slaughter in China, 2000-2012
China Swine Vaccine Market Size, 2012-2016E
Performance Comparison of Various Swine Fever Vaccines in China
China Poultry Vaccine Market Size, 2012-2016E
Newcastle Disease Vaccine Market Capacity and Ringpu Biology’s Market Share
China Cattle & Sheep Vaccine Market Size, 2012-2016E
China’s Per Capita GDP by Province/City, 2012
China Pet Vaccine Market Size, 2012-2016E
China Pet Vaccine Market Supply Companies 
Revenue and Net Income of CAHIC, 2008-2012
Revenue Breakdown of CAHIC by Product, 2010-2012
Revenue Structure of CAHIC by Product, 2010-2012
Revenue Breakdown of CAHIC by Region, 2010-2012
Revenue Structure of CAHIC by Region, 2010-2012
Gross Margin of Main Products of CAHIC, 2010-2012
Animal Vaccine Capacity Layout of CAHIC
Animal Vaccine Projects under Construction of CAHIC, 2013
Revenue and Net Income of CAHIC, 2011-2015E
Revenue and Net Income of Jinyu Group, 2008-2012
Revenue Breakdown of Jinyu Group by Product, 2010-2012
Revenue Structure of Jinyu Group by Product, 2010-2012
Revenue Breakdown of Jinyu Group by Region, 2010-2012
Revenue Structure of Jinyu Group by Region, 2010-2012
Gross Margin of Main Business of Jinyu Group, 2010-2012
R&D Costs and % of Total Revenue of Jinyu Group, 2010-2012
Animal Vaccine-related Subsidiaries of Jinyu Group, 2012
Revenue and Net Income of Jinyu Group, 2011-2015E
Revenue and Net Income of Tecon, 2008-2012
Revenue Breakdown of Tecon by Product, 2010-2012
Revenue Structure of Tecon by Product, 2010-2012
Revenue Breakdown of Tecon by Region, 2010-2012
Revenue Structure of Tecon by Region, 2010-2012
Gross Margin of Main Products of Tecon, 2010-2012
R&D Costs and % of Total Revenue of Tecon, 2010-2012
Tecon’s Revenue from Top 5 Clients and % of Total Revenue, 2010-2012
Name List and Revenue Contribution of Tecon’s Top 5 Clients, 2012
Tecon’s Procurement from Top 5 Suppliers and % of Total Procurement, 2012
Progress of Animal Vaccine R&D Projects of Tecon, 2012
Revenue and Net Income of Tecon, 2011-2015E
Revenue and Net Income of TECH-BANK, 2008-2012
Revenue Breakdown of TECH-BANK by Product, 2010-2012
Revenue Structure of TECH-BANK by Product, 2010-2012
Revenue Breakdown of TECH-BANK by Region, 2010-2012
Revenue Structure of TECH-BANK by Region, 2010-2012
Gross Margin of Main Products of TECH-BANK, 2010-2012
R&D Costs and % of Total Revenue of TECH-BANK, 2010-2012
Revenue and Net Income of Chengdu TECBOND Biological Products, 2010-2012
Revenue and Net Income of TECH-BANK, 2011-2015E
Revenue and Net Income of Shenghua Biok, 2008-2012
Revenue Breakdown of Shenghua Biok by Product, 2010-2012
Revenue Structure of Shenghua Biok by Product, 2010-2012
Revenue Breakdown of Shenghua Biok by Region, 2010-2012
Revenue Structure of Shenghua Biok by Region, 2010-2012
Gross Margin of Main Products of Shenghua Biok, 2010-2012
Shenghua Biok’s Revenue from Top 5 Clients and % of Total Revenue, 2010-2012
Name List and Revenue Contribution of Shenghua Biok’s Top 5 Clients, 2012
Revenue and Net Income of Qingdao Yebio Bioengineering, 2008-2012
Revenue and Net Income of Shenghua Biok, 2011-2015E
Revenue and Net Income of Huasun Group, 2008-2012
Revenue Breakdown of Huasun Group by Product, 2010-2012
Revenue Structure of Huasun Group by Product, 2010-2012
Revenue Breakdown of Huasun Group by Region, 2010-2012
Revenue Structure of Huasun Group by Region, 2010-2012
Gross Margin of Main Products of Huasun Group, 2010-2012
Huasun Group’s Revenue from Top 5 Clients and % of Total Revenue, 2010-2012
Name List and Revenue Contribution of Huasun Group’s Top 5 Clients, 2012
Huasun Group’s Procurement from Top 5 Suppliers and % of Total Procurement, 2010-2012
Name List and Procurement Contribution of Huasun Group’s Top 5 Suppliers, 2012
Revenue and Net Income of Ringpu Bio-technology, 2008-2012
Revenue Breakdown of Ringpu Bio-technology by Product, 2010-2012
Revenue Structure of Ringpu Bio-technology by Product, 2010-2012
Revenue Breakdown of Ringpu Bio-technology by Region, 2010-2012
Revenue Structure of Ringpu Bio-technology by Region, 2010-2012
Gross Margin of Main Products of Ringpu Bio-technology, 2010-2012
R&D Costs and % of Total Revenue of Ringpu Bio-technology, 2008-2012
Output and Sales Volume of Animal Vaccine Products of Ringpu Bio-technology, 2011-2012
Sales and Gross Margin of Animal Vaccine of Ringpu Bio-technology by Product, 2012 
Animal Vaccine Business-related Subsidiaries of Ringpu Bio-technology, 2012
Revenue and Net Income of Animal Vaccine Business-related Subsidiaries of Ringpu Bio-technology, 2012
Progress of Animal Vaccine-related Projects of Ringpu Bio-technology, 2012
Revenue and Net Income of Ringpu Bio-technology, 2011-2015E
Revenue and Net Income of Dahuanong, 2008-2012
Revenue Breakdown of Dahuanong by Product, 2010-2012
Revenue Structure of Dahuanong by Product, 2010-2012
Revenue Breakdown of Dahuanong by Region, 2010-2012
Revenue Structure of Dahuanong by Region, 2010-2012
Gross Margin of Main Products of Dahuanong, 2010-2012
R&D Costs and % of Total Revenue of Dahuanong, 2010-2012
Output, Sales Volume and Sales-Output Ratio of Veterinary Biological Products of Dahuanong, 2011-2012
Progress of Animal Vaccine-related Projects of Dahuanong by end-2012
Revenue and Net Income of Dahuanong, 2011-2015E
Revenue and Net Income of Yikang Biological, 2009-2011
Revenue Breakdown of Yikang Biological by Product, 2009-2011
Revenue Structure of Yikang Biological by Product, 2009-2011
Revenue Breakdown of Yikang Biological by Region, 2009-2011
Revenue Structure of Yikang Biological by Region, 2009-2011
Gross Margin of Main Products of Yikang Biological, 2009-2011 
R&D Costs and % of Total Revenue of Yikang Biological, 2009-2011
Yikang Biological’s Revenue from Top 5 Clients and % of Total Revenue, 2009-2011
Name List and Revenue Contribution of Yikang Biological’s Top 5 Clients, 2011
Yikang Biological’s Procurement from Top 5 Suppliers and % of Total Procurement, 2009-2011
Name List and Procurement Contribution of Yikang Biological’s Suppliers, 2011
Animal Vaccine Production Lines of Yikang Biological, 2009-2011
Capacity, Output and Capacity Utilization of Yikang Biological, 2009-2011
Output, Sales Volume and Sales-Output Ratio of Yikang Biological, 2009-2011
Average Sales Price of Main Products of Yikang Biological, 2009-2011
Revenue Structure of Yikang Biological by Sales Model, 2009-2011
Revenue and Net Income of Chopper Biology, 2009-2011
Revenue Breakdown of Chopper Biology by Product, 2009-2011
Revenue Structure of Chopper Biology by Product, 2009-2011
Revenue Breakdown of Chopper Biology by Region, 2009-2011
Revenue Structure of Chopper Biology by Region, 2009-2011
Gross Margin of Main Products of Chopper Biology, 2009-2011
R&D Costs and % of Total Revenue of Chopper Biology, 2009-2011
Chopper Biology’s Revenue from Top 5 Clients and % of Total Revenue, 2009-2011
Name List and Revenue Contribution of Chopper Biology’s Top 5 Clients, 2011
Sales Contract between Chopper Biology and Animal Husbandry and Veterinary Bureau of Hubei Province, 2011
Chopper Biology’s Procurement from Top 5 Suppliers and % of Total Procurement, 2009-2011
Name List and Procurement Contribution of Chopper Biology’s Suppliers, 2011
Sales of Major Vaccine Products of Chopper Biology, 2009-2011
Vaccine Capacity, Output and Capacity Utilization of Chopper Biology, 2009-2011
Vaccine Output, Sales Volume and Sales-Output Ratio of Chopper Biology, 2009-2011
Average Sales Price of Major Vaccine Products of Chopper Biology, 2009-2011
Investment Plan of Chopper Biology, 2012 

China Vacuum Blood Collection Industry Report, 2014-2017

The vacuum blood collection system consisting of vacuum blood collection tubes, disposable blood collection needles, tourniquets, etc transfers human venous blood to closed containers and makes it int...

China Pharmaceutical Excipients Industry Report, 2014-2017

Pharmaceutical excipients refer to adjuvants and additives used for production of pharmaceuticals and compounding of prescriptions. In addition to active ingredients, pharmaceutical excipients are als...

China Recombinant Protein Drug Industry Report, 2014-2017

The Chinese recombinant protein drug market has been expanding rapidly owing to the improvement of demand rigidity, consumption ability and the like. During 2005-2013, sales of recombinant protein dru...

China Heparin Industry Report, 2014-2017

As the world's major heparin API producer and exporter, China boasts enormous raw materials, which provides a strong support for the production of China’s heparin products. In 2013, the live pigs rais...

Global and China Monoclonal Antibody Industry Report, 2014-2019

Despite world-wide economic downturn and great changes in exchange rate, benefiting from robust market demand, global monoclonal antibody market size exceeded USD 80 billion in 2013, still one of biot...

Global and China DNA Sequencing Industry Research Report, 2014-2017

DNA sequencing is the process of reading nucleotide bases in a specific DNA molecule, that is to say determining the arrangement mode of adenine, thymine, cytosine, and guanine. It can be applied in a...

Global and China Stem Cell Industry Report, 2014-2017

Stem cells are undifferentiated biological cells that can differentiate into specialized cells and can divide (through mitosis) to produce more stem cells. Stem cell therapy can be applied to treatmen...

China Human Vaccine Industry Report, 2014-2017

Vaccines can prevent and control infectious diseases, so the demand for these biological products is relatively rigid. In 2013, China’s human vaccine lot release volume grew by 4.9% from a year earlie...

China Blood Product Industry Report, 2014-2017

Plasma resource reserves and control are crucial to the development of blood products industry. Although the closure of 16 plasma collection stations in Guizhou in 2011 didn’t cause major disruption t...

China Animal Vaccine Industry Report, 2013-2016

Animal vaccine is a kind of biological agent that enables inoculated animals to produce active immunity for disease prevention. Europe and the United States and other developed countries are the main ...

China Contract Research Organization (CRO) Industry Report, 2013-2016

China CRO industry has developed rapidly in recent years, registering a CAGR of 27.2% during 2007-2013, of which the market size reached RMB 36 billion in 2013, occupying 10% of global market share. ...

Global and China Biodegradable Plastics Industry Report, 2013-2016

Global biodegradable plastic production and demand have grown rapidly in recent years, and the capacity reached 1-1.5 million t/a in 2012-2013. Among dozens of biodegradable plastic varieties develope...

Global and China Industrial Enzyme Industry Report, 2014-2016

In 2007-2013, the global industrial enzyme market size grew at the CAGR of 5.7%, reaching USD4.04 billion in 2013, 1.4 times that in 2007. The global industrial enzyme market is monopolized by a small...

China Heparin Industry Report, 2013-2015

Since the small intestines of pigs (raw materials for production of heparin) in China are abundant (the pig slaughtering volume in China approximates 50% of globe’s total) and heparin APIs are gradual...

China Lactic Acid and Derivative Industry Report, 2013

China’s lactic acid capacity and output continued to grow at the respective CAGR of 22.7% and 28.7% in 2007-2011. But limited by market demand, the annual output of most vendors was below their design...

China Human Vaccine Industry Report, 2012-2015

In the wake of China's economic growth and enhanced disease prevention awareness, Chinese human vaccine market has been expanding. In 2012, Chinese human vaccine market valued RMB10.5 billion with the...

China Blood Product Industry Report, 2012-2015

Plasma is a key raw material of the blood product industry. In August 2011, China shut down 16 plasma stations in Guizhou, resulting in a decrease of 15% in the plasma volume of the year. However, due...

China Animal Vaccine Industry Report, 2012-2015

In view of the frequent occurrence of animal epidemic diseases over the years, the Chinese government has increased investment in epidemic prevention and implemented compulsory immunization system. Be...

2005-2014 All Rights Reserved 京ICP备05069564号-1 京公网安备1101054484号